Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

TP protocol × Other solid neoplasm × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 17 Thoracic 5 Gynecologic 5 Head & Neck 4 Breast 2 Other solid neoplasm 1 Dermatologic 1

Conditions

Solid Tumor Cancer 1

Interventions

Cisplatin 132 pembrolizumab 110 Carboplatin 109 Paclitaxel 90 Injections 87 Pemetrexed 83 Gemcitabine 76 Irinotecan 66 Cyclophosphamide 63 Docetaxel 59 Nivolumab 57 Bevacizumab 54 Fluorouracil 46 Oxaliplatin 44 Capecitabine 43 atezolizumab 39 Leucovorin 39 tislelizumab 36 Etoposide 34 toripalimab 28 fludarabine 28 Ipilimumab 27 Topotecan 24 Radiotherapy 24 durvalumab 23 Drug Therapy 23 Specimen Handling 22 Sorafenib 22 Early Intervention, Educational 22 Doxorubicin 22

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06649448 2024-10-18

EF-001

Shandong Cancer Hospital and Institute

Phase NA Not yet recruiting

Other solid neoplasm

Solid Tumor Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡